89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry.
about
Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression.Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.PET Radiometals for Antibody Labeling.Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer ManagementApplication of Immuno-PET in Antibody-Drug Conjugate Development
P2860
89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
89Zr-Immuno-Positron Emission ...... f-the-Art 89Zr Radiochemistry.
@en
type
label
89Zr-Immuno-Positron Emission ...... f-the-Art 89Zr Radiochemistry.
@en
prefLabel
89Zr-Immuno-Positron Emission ...... f-the-Art 89Zr Radiochemistry.
@en
P2093
P2860
P50
P921
P1476
89Zr-Immuno-Positron Emission ...... of-the-Art 89Zr Radiochemistry
@en
P2093
Franck Denat
Mark Rijpkema
Otto Boerman
P2860
P304
P356
10.1021/ACS.BIOCONJCHEM.7B00325
P577
2017-08-24T00:00:00Z